The protective effect of Andrograhis paniculata and andrographolide (ANDLE) against cyclophosphamide (CTX)induced urothelial toxicity was investigated in this study. Pretreatment of Swiss albino mice with A paniculata extract (10 mg/dose/animal intraperitoneally [ip]) and ANDLE (500 µg/dose/animal ip) could significantly reduce CTX (1.5 nmol/kg body weight)-induced urothelial toxicity. Morphological and histopathological analysis of urinary bladder of CTX-treated mice showed severe inflammation and dark coloration, whereas A paniculata and ANDLEtreated mice showed almost normal bladder morphology. Elevation of urinary protein level (7.33 ± 0.3 g/L) by CTX administration was reduced by A paniculata (3.78 ± 0.4 g/L) and ANDLE treatment (4.19 ± 0.1 g/L). Urinary urea N 2 level, which was elevated after 48 hours of CTX administration (24.25 ± 0.2 g/L) was found to be reduced by the treatment with A paniculata (14.19 ± 0.5 g/L) and ANDLE (15.79 ± 0.4 g/L). A decreased level of reduced glutahione (GSH) content in liver (2.81 ± 0.1 nmol/mg protein) and bladder (1.20 ± 0.2 nmol/mg protein) after CTX administration was also increased by the treatment with A paniculata (liver: 5.78 ± 0.3 nmol/mg protein; bladder: 2.96 ± 0.2 nmol/mg protein) and ANDLE (liver: 5.14 ± 0.3 nmol/mg protein; bladder: 2.84 ± 0.2 nmol/mg protein). Production of the proinflammatory cytokine, tumor necrosis factor-α, which was elevated during CTX administration, was found to be inhibited by A paniculata and ANDLE treatment. The lowered level of interleukin-2 and interferon-γ during CTX treatment was elevated by the administration of A paniculata and ANDLE.
Cyclophosphamide (CTX), a cytotoxic alkylating agent belonging to the class of oxazaphosphorines, is used in chemotherapeutic regimens of lymphoproliferative disorders, certain solid tumors, and nonneoplastic diseases such as nephrotic syndrome, systemic lupus erythematosus, and rheumatoid arthritis. 1 Use of CTX as an effective chemotherapeutic agent is often restricted because of its widespread adverse side effects and toxicity, which include nausea, vomiting, alopecia, hemopoietic suppression, nephrotoxicity, immunotoxicity, mutagenicity, carcinogenicity teratogenicity, and urotoxicity. 2, 3 The major damage to the urinary bladder by CTX is hemorrhagic cystitis and edema, 4 which has been a main problem for physicians during chemotherapy.
CTX itself is inactive and must first undergo metabolic activation, catalyzed by the hepatic cytochrome P450 to 4-hydroxy-cyclophosphamide and later to phosphoramide mustard and acrolein. 5 The mustard component produces a cytotoxic effect by preventing cell replication, while acrolein is responsible for urothelial damage. It has been reported that urothelial damage such as edema, ulceration, neovascularization, hemorrhagic cystitis, and necrosis occurs by direct contact with acrolein. 6 Although the toxicities associated with CTX are serious, this agent remains a highly effective drug in many pathological situations.
A synthetic sulfhydryl compound, 2 mercaptoethanesulfonate (MESNA), is given simultaneously with CTX to patients to ameliorate the urothelial damage due to CTX. MESNA is rapidly metabolized to mesna disulfide, which reacts with the urotoxic metabolite of CTX, acrolein, to detoxify it. But MESNA itself shows some adverse effects, such as hypersensitivity reactions, headache, depression, fatigue, nausea, vomiting, and diarrhea. 7 Although many attempts have been made, including application of prostaglandins E 1 , 8 E 2 , 9 and F2α, 10, 11 which bind and inhibit the toxicity of acrolein, an ideal clinical therapy is still not available. So it has been a high medical priority to discover an effective therapy for CTX-induced urothelial toxicity.
CTX is now being used in combination with various detoxifying and protective agents with the purpose of reducing or eliminating its adverse toxic effects. It has been reported that, many plant extracts such as Phyllanthus amarus, 12 Cassia occidentalis, 13 and Emblica officinalis 14, 15 have exhibited ameliorating effects on CTX toxicity. Berberine, an alkaloid isolated from many medicinal plants such as Berberis and Coptis, is also used as an effective drug in the treatment of CTX-induced cystitis. 16 Previous work in our laboratory has found that treatment with the extract of Withania somnifera 17 and sulphur-containing compounds 18, 19 effectively eliminated the urotoxicity induced by CTX in Swiss albino mice. This demonstrates that plant extracts have great potential in reducing the toxicity of CTX.
Andrographis paniculata (Burm F) Wall Ex Nees (family Acanthaceae) is an erect annual herb, extremely bitter in taste in each and every plant part. It is used in the Indian traditional system of medicine against various diseases 20 and also as a natural remedy for gastrointestinal disorders, sluggish fever, jaundice, and malaria. The plant has been reported to possess antidiabetic, 21 antipyretic, 22 and hepatoprotective properties. 23 Andrographolide, a diterpene lactone, the major component of A paniculata, also exhibits antiulcerogeneic, antipyretic, 24 and anti-inflammatory activities, 25 but very little is known with regard to its effect against CTX-induced urothelial toxicity. Therefore, in this study, an attempt has been made to investigate the protective effect of A paniculata and andrographolide against CTX-induced urothelial toxicity in Swiss albino mice.
Materials and Methods

Animals
Swiss albino mice (25-28 g, 6-8 weeks old) were taken from the breeding section of Amala Cancer Research Centre. The animals were fed with normal mouse chow (Sai Durga Feeds and Foods, Bangalore, India) and water ad libitum. All the animal experiments were performed according to the rules and regulations of the Animal Ethics Committee, Government of India.
Chemicals
MESNA and urea analyzing kits were obtained from SPAN Diagnostics Ltd (Surat, India). Glutathione (GSH) and 5-5 dithiobis-2-nitrobenzoic acid (DTNB; Ellman's reagent) were obtained from SISCO Research Laboratory (Bombay, India).
Enzyme-Linked Immunosorbent Assay Kit
Highly specific quantitative sandwich enzyme-linked immunosorbent assay kits for mouse interleukin-2 (IL-2), interferon-γ (IFN-α), and tumor necrosis factor-α (TNF-α) were purchased from Pierce Biotechnology (Rockford, Ill).
Preparation of Plant Extract
The air-dried whole plant was powdered and extracted using 70% ethanol by stirring overnight at 4°C. Supernatant was collected after centrifuging at 10 000 rpm at 4°C for 10 minutes. Ethanol was removed by evaporation, and the yield of the extract was 14%. Phytochemical analysis showed the presence of terpenoids and flavonoids.
Isolation of Andrographolide
The major component of A paniculata, andrographolide (ANDLE; Figure 1 ), was isolated according to the method of Handa and Sharma. 26 Briefly, the whole plant material was dried, powdered, and extracted at room temperature successively with 4 times 40-L petroleum ether (60°C-80°C), chloroform, and methanol in soxhlet extraction assembly. The methanolic extract was concentrated, and activated charcoal (400 g) was added to it. After 24 hours, the charcoal was filtered off, and the filtrate was concentrated under reduced pressure and left overnight for crystallization. The crystals were collected by filtration and purified by recrystallization. The isolated andrographolide was compared with an authentic sample by thin-layer chromatography. The purity of the isolated compound was determined by melting point (230°C), ultraviolet absorption (maximum at 225 nm), 13 C NMR, and mass spectrum.
Drug Administration
For animal studies A paniculata extract and andrographolide were suspended in 1% gum acacia. A paniculata extract was administered at a dosage of 10 mg/dose/animal and ANDLE at a dosage of 500 µg/dose/animal intraperitoneally.
Determination of the Effect of A paniculata and ANDLE on CTX-Induced Urothelial Toxicity
Six groups of 6-to 8-week-old male Swiss albino mice (18 animals/group) were used for the study, of which 4 groups (groups 1-4) were treated with a single acute dose of CTX (1.5 nmol/kg body weight). Group 1 animals were kept as a CTX-only-treated control (hereafter CTX only). Group 2 and group 3 animals were treated with A paniculata (10 mg/dose/animal) and ANDLE (500 µg/dose/ animal), respectively, for 5 days before CTX administration. Group 4 animals were treated with a single dose of the known synthetic uroprotector, MESNA (4.5 nmol/animal), along with CTX. Two other groups of animals (groups 5 and 6) were treated with 5 doses of A paniculata and ANDLE alone. Animals were kept in metabolic cages to collect the urine in clean sterile vials, which was used to estimate urine urea and urea N 2 levels. Six animals from group 1, 2, 3, and 4 were killed by cervical dislocation at different time periods (4 hours, 24 hours, and 48 hours) after CTX administration. Animals treated with A paniculata and ANDLE alone were killed 24 hours after the last dose of the drug administration. The body weight of the animals was recorded prior to the drug administration and just before sacrifice. Immediately after blood was collected by heart puncture in a clean sterile glass tube, the serum was separated and used to estimate various cytokine levels such as IL-2, IFN-γ, and TNF-α. Urinary bladder and liver were excised, weighed, and used for assessing all the following parameters.
Morphological Analysis
The urinary bladder was excised from each animal immediately after sacrifice and washed thoroughly in phosphate buffer (pH 7.4), and all the surrounding connective tissues were removed. Bladder weight, macroscopic observations (changes in color, size, etc) were recorded to evaluate the effect of A paniculata and ANDLE during CTX administration.
Biochemical Parameters
Liver homogenate (25%) and urinary bladder homogenate (10%) were prepared and used for the estimation of GSH content according to the method of Moron et al. 27 Briefly, proteins were precipitated by adding 125 µL of 20% trichloroacetic acid (TCA) to 0.5 mL of tissue homogenate and were incubated on ice for 5 minutes. The mixture was further diluted with 0.6 mL of 5% TCA and centrifuged at 1000 rpm for 10 minutes, and the supernatant (0.1 mL) was made up to 1 mL with 0.2 M phosphate buffer (pH 8.0). Freshly prepared DTNB solution in 0.2 M sodium phosphate buffer (2 mL) was added, and a yellow color formed after 10 minutes was measured in a spectrophotometer at 412 nm. The total protein content was estimated by the method of Lowry et al 28 using bovine serum albumin as a standard.
Histopathological Analysis
Urinary bladder samples were fixed in 10% formaldehyde. After several treatments in various concentrations of alcohol, the dehydrated tissue was embedded in paraffin wax. Sections (4 µm) were cut and stained with hematoxylin and eosin, and histopathological analysis was carried out.
Data Analysis
All data are expressed as means ± standard deviations. The normal control (without any treatment) was compared with the CTX-only group by Student t test. The CTX-only treatment group was compared with CTX + A paniculata, CTX + ANDLE, and CTX + MESNA groups by 1-way ANOVA followed by a Bonferonni multiple comparison test. The A paniculata and ANDLE-only group was compared with the normal group by 1-way ANOVA followed by a Bonferonni multiple comparison test.
Results
Effect of A paniculata and ANDLE on the Inflammation of Urinary Bladder After CTX Administration
Control animals treated with CTX alone showed inflamed bladder with a reddish color after 4 hours of CTX administration. In the treated groups, CTX plus A paniculata and ANDLE showed only slight inflammation and red coloration at the same time point. After 24 hours, the urinary bladder showed high inflammation and dark red color in the CTX-treated control group, but in the CTX + A paniculata and ANDLE groups, there was no inflammation. Even after 48 hours, the urinary bladders of the CTX-only group of animals were severely inflamed with dark red coloration, whereas in the CTX + A paniculata and ANDLE groups, the urinary bladders appeared normal. The urinary bladders of the animals that received A paniculata and ANDLE alone did not show any kind of changes in color or size even after 48 hours. The morphological observation of urinary bladder inflammation was confirmed by histopathological analysis. Figure 2 shows the urinary bladder histopathology of mice treated with CTX in the presence and absence of A paniculata and ANDLE at different time intervals. Animals treated with CTX alone showed severe damage to the urothelium, including mucosal erosion, inflammatory cell infiltration, fibrin deposition, necrosis, and multiple ulcerations (Figure 2A-C) . However, animals treated with 5 doses of A paniculata (10 mg/dose/animal; Figure 2D -F) and ANDLE (500 µg/dose/animal; Figure 2G , H, and J) along with CTX had reduced bladder damage, characterized by urothelium preservation, absence of edema, leukocyte infiltration, and ulceration.
Effect of A paniculata and ANDLE on Total Protein Content in Urine of CTX-Treated Animals
The total protein level in urine was drastically increased 4 hours after CTX administration in control animals (8.59 ± 0.2 g/L) compared with normal animals (3.59 ± 0.1 g/L; Table 1 ). This elevated 
Effect of A paniculata and ANDLE on Urea N 2 Level in Urine After CTX Treatment
Analysis of urine of CTX + A paniculata and CTX + ANDLE groups of animals after 4 hours, 24 hours, and 48 hours showed that the urea N 2 level in urine, which was enhanced by CTX administration (Tables 1-3) , was reduced significantly. The normal level of urine urea N 2 was 16.19 ± 0.8 g/L. After 4 hours, urinary urea N 2 in the CTX-only group was 26.15 ± 0.8 g/L. Even after 48 hours, the level of urea N 2 remained elevated (24.5 ± 0.2 g/L). However, after 4 hours in the CTX + A paniculata group, urinary urea N 2 was 18.58 ± 0.4 g/L, and in the CTX + ANDLE group, it was 20.25 ± 0.5 g/L. After 24 hours in the CTX + A paniculata and ANDLE animals, urinary urea N 2 level was normalized and was only 15.79 ± 0.4 g/L and 16.20 ± 0.7 g/L, respectively.
Effect of A paniculata and ANDLE on GSH in Liver and Bladder After CTX Administration
The normal GSH level in both liver (6.10 ± 0.7 nmol/mg protein) and bladder (2.58 ± 0.3 nmol/mg protein) was drastically reduced to 2.80 ± 0.1 nmol/mg protein in liver and 0.92 ± 0.1 nmol/mg protein in bladder 4 hours after CTX administration, and it remained at the lowered level even after 48 hours (Tables 1-3 ). However, treatment with A paniculata and ANDLE enhanced the liver GSH to 3.70 ± 0.1 nmol/mg protein (A. paniculata) and 3.30 ± 0.1 nmol/mg protein (ANDLE) and bladder GSH to 1.76 ± 0.2 (A paniculata) and 1.38 ± 0.3 (ANDLE) 4
hours after CTX administration. The level of GSH in both bladder and liver was normalized by 48 hours in A paniculata extract and ANDLE groups.
Effect of A paniculata and ANDLE on Serum Cytokine Levels in CTX-Treated Mice
Cytokines such as IFN-γ, IL-2, and TNF-α in the serum of CTX-treated animals showed a varying pattern during the period of study (Table 4 ). In control animals, the level of IFN-γ in the serum was reduced to 1266.90 ± 17.6 pg/mL after 4 hours of CTX treatment compared with normal animals (1980.46 ± 34.9 pg/mL), and it was again reduced to 762.69 ± 20.0 pg/mL after 48 hours. The IFN-γ level was elevated to 1944.03 ± 13.4 pg/mL after 4 hours and to 2092.30 ± 67.5 pg/mL after 48 hours by A paniculata treatment, while ANDLE administration elevated the IFN-γ level to 1810.10 ± 90 pg/mL and 1839.80 ± 51.3 pg/mL at 4 and 48 hours, respectively. IL-2 levels were found to be highly reduced after 4 hours (7.51 ± 0.1 pg/mL) and 48 hours (4.48 ± 0.2 pg/mL) in CTX-treated control animals compared to normal levels (11.08 ± 0.5 pg/mL). A paniculata treatment could elevate the reduced level to 23.66 ± 0.8 pg/mL after 4 hours and 30.35 ± 0.4 pg/mL after 48 hours, while ANDLE animals showed elevated levels of IL-2 (18.83 ± 0.9 pg/mL) and 20.60 ± 0.3 pg/mL after 4 and 48 hours, respectively.
The level of serum TNF-α in CTX-only control animals was elevated at 4 and 48 hours to 123.60 ± 3 pg/mL and 286.06 ± 47.4 pg/mL, respectively. In the A paniculata group, it was reduced to 90.04 ± 1.5 pg/mL at 4 hours and 65.44 ± 0.9 pg/mL after 48 hours, while ANDLE treatment reduced the TNF-α level to 112.72 ± 6.0 pg/mL after 4 hours and 88.84 ± 0.9 pg/mL after 48 hours. 
Discussion
In the present study, we aimed to analyze whether A paniculata extract and its major component andrographolide could prevent the urothelial toxicity induced by CTX. The result shows that prior administration of A paniculata and ANDLE prevented the urothelial damage induced by CTX. The low dose of CTX is immunostimulative by inhibiting nitric oxide (NO) production, 29 but the clinically applied dose causes severe side effects such as leucopenia, hematuria, and urinary bladder damage (hemorrhagic cystitis). 30 In addition, it causes depression of hepatic microsomal enzyme activities. 30 In this study, we used a high dose of CTX to make a typical animal model that shows serious bladder damage, such as edema, necrosis, and so forth. Intraperitoneal administration of CTX alone produced a marked increase in bladder weight and reduction in body weight. It also resulted in urinary bladder color change due to hemorrhagic cystitis, necrosis, inflammation, and so on. Acrolein, the urotoxic metabolite of CTX present in the urine of CTX-treated animals, is responsible for the undesirable side effects in the urinary bladder. 30 Although the entire urine-collecting system is at risk, the bladder is most susceptible to damage because it collects urine for a longer period before being excreted compared to other regions. Administration of MESNA with CTX protects against urinary bladder damage and enzymatic inactivation but not leucopenia. 30 It also produces other adverse side effects, 7 while treatment of A paniculata and ANDLE diminished the CTX-induced edema and hemorrhage in the urinary bladder without any side effects. Urothelial architecture of these animals was similar to normal with smaller numbers of necrotized cells, demonstrating uroprotective activity of A paniculata and andrographolide. Accumulation of the CTX metabolite acrolein in the urinary bladder induces reactive oxygen species (ROS) production. Ozcan et al 31 reported that the overproduction of ROS during CTX-mediated inflammation is one reason for possible urothelial injury. GSH is a nonenzymatic antioxidant that plays an important role in the detoxifying pathway and protects the cell from ROS. The acrolein and ROS generated in the body by CTX treatment decreases the liver and bladder GSH level. The depletion of GSH also results in the inhibition of glutathione peroxidase, making the cells more vulnerable to oxidative stress, which is detrimental to the cells. 32 Treatment with A paniculata and ANDLE showed elevated levels of GSH in the liver as well as bladder, which revealed that the increased GSH activity may also contribute its protective effect against CTX-induced oxidative stress.
Cytokines and the inducible NO synthase (iNOS)/ NO system play an important role in the pathogenesis of CTX-induced cystitis, 33 acute and chronic inflammation. [34] [35] [36] NO is a highly reactive free radical that has emerged as a potent biological mediator and neurotransmitter in the immune system. [37] [38] [39] [40] The elevated level of the NO metabolites is associated with the severity of CTX-induced bladder injury. 41 iNOS can be activated by proinflammatory cytokines, which may lead to organ destruction and may participate in inflammatory diseases. The elevated level of TNF-α, the principal cytokine that mediates acute inflammation after CTX administration, was reduced by A paniculata and ANDLE treatment, indicating their protective effect against CTX-induced inflammation. Earlier, it was observed that neoandrographolide, another component present in A paniculata, inhibited NO production by activated macrophages. 42 In this study, we have found that A paniculata and ANDLE reduced the urinary urea N 2 content in the CTX-treated mice, while in the CTXonly mice, it remained at the elevated level, clearly revealing that administration of A paniculata and ANDLE could reduce the level of NO metabolite and protect mice from urinary bladder injury. Similarly, urine protein, which was also enhanced significantly in untreated control animals compared to normal animals, was effectively brought back to normal level after treatment with A paniculata and ANDLE. It was also found that administration of A paniculata and ANDLE increased the level of various other cytokines such as IL-2 and IFN-γ, which were reduced by CTX administration. These cytokines are mainly involved in augmenting the activity of natural killer cells of the immune system and increasing the production of other cytokines, protecting mice against the toxic effect of the CTX.
The immunological and biochemical evaluations in the current study showed that A paniculata and the major component ANDLE could effectively protect the CTX-induced urinary bladder toxicity in Swiss albino mice. Since both the extract and ANDLE exhibited the uroprotective activity, this study also confirmed that the presence of andrographolide is responsible for uroprotective activity of the extract. Detailed studies are needed to unravel the exact mechanism of action underlying this uroprotection.
